Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

Published:2012-07-11 Issue:1 Volume:225 Page:51-59
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Asadabadi Mahtab,Mohammadi Mohammad-Reza,Ghanizadeh Ahmad,Modabbernia Amirhossein,Ashrafi Mandana,Hassanzadeh Elmira,Forghani Saeedeh,Akhondzadeh Shahin

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-012-2796-8.pdf

Reference48 articles.

1. Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S (2012) Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord. doi: 10.1016/j.jad.2012.03.033

2. Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B (2007) Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophr Res 90:179–185

3. Akhondzadeh S, Tajdar H, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Shabstari OL, Ghelichnia HA (2008) A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder. Child Psychiatry Hum Dev 39:237–245

4. Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, Mohebbi-Rasa S, Raznahan M, Kamalipour A (2009) Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 26:607–611

5. Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B, Ghanizadeh A, Raznahan M, Mohebbi-Rasa S, Rezazadeh SA, Forghani S (2010) Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism. Prog Neuropsychopharmacol Biol Psychiatry 34:32–36

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the critical role of neuroinflammation in epilepsy-associated neuropsychiatric comorbidities: A review;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2025-01

2. Autism spectrum disorder and a possible role of anti-inflammatory treatments: experience in the pediatric allergy/immunology clinic;Frontiers in Psychiatry;2024-06-24

3. Emerging drugs for the treatment of irritability associated with autism spectrum disorder;Expert Opinion on Emerging Drugs;2024-01-02

4. Role of oxidative stress in the pathogenesis of autism spectrum disorders;Reviews on Clinical Pharmacology and Drug Therapy;2023-10-10

5. Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD);Cochrane Database of Systematic Reviews;2023-10-09